Vident Advisory’s Nomura Holdings NMR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.42M Buy
307,268
+35,773
+13% +$308K 0.02% 569
2025
Q4
$2.28M Sell
271,495
-38,802
-13% -$290K 0.02% 531
2025
Q3
$2.26M Buy
310,297
+16,702
+6% +$117K 0.02% 538
2025
Q2
$1.93M Buy
293,595
+42,098
+17% +$246K 0.02% 513
2025
Q1
$1.55M Buy
251,497
+34,063
+16% +$217K 0.02% 569
2024
Q4
$1.26M Buy
217,434
+6,074
+3% +$34.5K 0.02% 561
2024
Q3
$1.1M Buy
211,360
+22,874
+12% +$130K 0.03% 596
2024
Q2
$1.09M Buy
188,486
+42,854
+29% +$254K 0.03% 564
2024
Q1
$935K Buy
145,632
+12,374
+9% +$68.7K 0.02% 598
2023
Q4
$601K Buy
133,258
+21,356
+19% +$87.9K 0.02% 709
2023
Q3
$450K Buy
+111,902
New +$446K 0.01% 738

Other funds holding NMR

Vident Advisory's NMR Position: Q1 2026 in Review

Vident Advisory increased its Nomura Holdings (NMR) stake by 13% in Q1 2026, buying an estimated $308K and bringing the position to 307,268 shares worth $2.42M. The position accounts for 0.02% of the portfolio, ranked #569.

Vident Advisory first reported a position in NMR in Q3 2023 and has held it in 11 quarters since. 271 funds tracked by Wall St. Rank hold NMR as of Q1 2026.

  • Vident Advisory held 307,268 shares of Nomura Holdings worth $2.42M as of Q1 2026.
  • Vident Advisory bought 35,773 Nomura Holdings shares in Q1 2026, an estimated $308K.
  • Nomura Holdings made up 0.02% of Vident Advisory's portfolio in Q1 2026, its #569 holding.
  • Vident Advisory first reported a position in Nomura Holdings in Q3 2023 and has held it in 11 quarters since.
  • 271 funds tracked by Wall St. Rank held Nomura Holdings as of Q1 2026.

Based on Vident Advisory's 13F filing for Q1 2026, filed 15 May 2026.